Physician profile
Daniel Joyce
NPI 1386922698
$7,406.87
in general payments reported to CMS, 2019-2025
18 companies · $753 in 2025
The $753 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,160 · 2021: $314 · 2022: $658 · 2023: $781 · 2024: $2,741 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,818 · Travel and Lodging: $1,448 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,817.96 |
| Travel and Lodging | $1,448.08 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,263.17 | 2019-2025 | |
| Boston Scientific Corporation | $856.55 | 2021-2025 | Spyglass Discover |
| Dilon Technologies, INC. | $436.28 | 2023-2024 | Hemoblast Bellows |
| Teleflex LLC | $339.93 | 2022-2023 | Quikclot |
| W. L. Gore & Associates, INC. | $223.24 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $219.83 | 2024 | |
| Innovation Technologies INC | $156.82 | 2025 | Irrisept |
| Kerecis Limited | $147.10 | 2022 | |
| Baxter Healthcare | $136.00 | 2025 | Floseal |
| Astrazeneca Pharmaceuticals Lp | $118.53 | 2025 | |
| Angiodynamics, INC. | $117.00 | 2025 | Nanoknife |
| Solventum Corporation | $116.36 | 2024 | V.A.C.Instill, Prevena, Abthera Advance |
| Abbvie INC. | $86.99 | 2023 | |
| Vivus LLC | $71.22 | 2023 | Qsymia |
| Medical Device Business Services, INC. | $49.24 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.43 | 2021 | |
| Merck Sharp & Dohme LLC | $23.11 | 2024 | Dificid |
| Ethicon US, LLC | $22.07 | 2023 | Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Joyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.